Stay updated on Nivolumab for Uterine Cancer - Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No other content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:44.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Page revision tag updated to v3.5.0, replacing the previous v3.4.3. This appears to be a minor maintenance update unrelated to study data or usability.
    Difference
    0.1%
    Check dated 2026-03-19T04:50:28.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision label has been updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:42.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed earlier notices including Revision: v3.4.1 and the government funding status notice with links to operating status.
    Difference
    0.4%
    Check dated 2026-02-11T11:00:05.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH Clinical Center operating status added; revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:20:38.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated QC/versioning labels: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older forms 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:16:57.000Z thumbnail image

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.